CompaniesFlen Pharma

Flen Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

84

By Phase

PHASE1/PHASE2: 2PHASE2: 2

By Status

TERMINATED: 3WITHDRAWN: 1AVAILABLE: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
Today
NCT03196375
NCT03254199
NCT03338114
Hover over trial bars to see details

Recent Trials

NCT03334786Lead Sponsor
Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS
PHASE1/PHASE2Terminated
3 participants
Started: Apr 5, 2018 · Completed: Aug 23, 2018
NCT03338114Lead Sponsor
Study to Evaluate the Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Upper or Lower Extremity Muscles Most Affected in Subjects With ALS
PHASE1/PHASE2Withdrawn
Started: Nov 30, 2017 · Completed: Aug 31, 2018
NCT03254199Lead Sponsor
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.
PHASE2Terminated
27 participants
Started: Oct 16, 2017 · Completed: Jul 27, 2018
NCT03196375Lead Sponsor
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
PHASE2Terminated
54 participants
Started: Jul 28, 2017 · Completed: Jul 27, 2018
NCT04132882Collaborator
A Compassionate Use Program to Provide Access to Sodium Thiosulfate
N/AAVAILABLE